PDCD1 and cancer: Allison and Honjo’s discovery of T-cell immune checkpoints CTLA-4 and PD-1, which awarded them the Nobel Prize in Physiology or Medicine in 2018, propelled the cancer immunology field into the present era of cancer immunotherapy.